Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 13 (Search time: 0.004 seconds).
previous
1
2
next
Item hits:
Preview
Issue Date
Title
Author(s)
2014
Achieving the deep molecular response levels required for an imatinib discontinuation trial is strongly associated with the BCR-ABL level at the first qualifying timepoint
Branford, S.
;
Ross, D.
;
Yeung, D.
;
Braley, J.
;
Hughes, T.
;
56th ASH Annual Meeting (6 Dec 2014 - 9 Dec 2014 : San Francisco, California)
2010
Selective escalation of imatinib therapy and early switching to nilotinib in de novo chronic phase CML patients: interim results from the TIDELL-II trial
Yeung, D.
;
Osborn, M.
;
White, D.
;
Branford, S.
;
Haswell, L.
;
Slader, C.
;
Issa, S.
;
Hiwase, D.
;
Hertzberg, M.
;
Schwarer, A.
;
Filshie, R.
;
Arthur, C.
;
Kwan, Y.
;
Forsyth, C.
;
Ross, D.
;
Mills, A.
;
Grigg, A.
;
Hughes, T.
;
Annual Meeting of the American Society of Hematology (52nd : 2010 : Orlando, Fl.)
2014
The adverse effect of high sokal risk for first line imatinib treated patients is overcome by a rapid rate of BCR-ABL decline measured as early as 1 month of treatment
Branford, S.
;
Yeung, D.
;
Ross, D.
;
Parker, W.
;
Braley, J.
;
Seymour, J.
;
Hughes, T.
;
56th ASH Annual Meeting (6 Dec 2014 - 9 Dec 2014 : San Francisco, California)
2013
PCR-mediated recombination can lead to artificial chimera formation, which may pose as BCR-ABL1 compound mutations
Parker, W.
;
Phillis, S.
;
Yeung, D.
;
Hughes, T.
;
Scott, H.
;
Branford, S.
;
55th American Society of Hematology Annual Meeting and Exhibition (7 Dec 2013 - 10 Dec 2013 : New Orleans, Louisiana)
2014
Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline
Branford, S.
;
Yeung, D.
;
Parker, W.
;
Roberts, N.
;
Purins, L.
;
Braley, J.
;
Altamura, H.
;
Yeoman, A.
;
Georgievski, J.
;
Jamison, B.
;
Phillis, S.
;
Donaldson, Z.
;
Leong, M.
;
Fletcher, L.
;
Seymour, J.
;
Grigg, A.
;
Ross, D.
;
Hughes, T.
2014
Many BCR-ABL1 compound mutations reported in chronic myeloid leukemia patients may actually be artifacts due to PCR-mediated recombination
Parker, W.
;
Phillis, S.
;
Yeung, D.
;
Hughes, T.
;
Scott, H.
;
Branford, S.
2018
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells
Ross, D.
;
Pagani, I.
;
Shanmuganathan, N.
;
Kok, C.
;
Seymour, J.
;
Mills, A.
;
Filshie, R.
;
Arthur, C.
;
Dang, P.
;
Saunders, V.
;
Braley, J.
;
Yong, A.
;
Yeung, D.
;
White, D.
;
Grigg, A.
;
Schwarer, A.
;
Branford, S.
;
Hughes, T.
2013
BCR-ABL1 kinase domain mutations may persist at very low levels for many years and lead to subsequent TKI resistance
Parker, W.
;
Yeoman, A.
;
Jamison, B.
;
Yeung, D.
;
Scott, H.
;
Hughes, T.
;
Branford, S.
2015
KIR2DL5B genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy
Yeung, D.
;
Tang, C.
;
Vidovic, L.
;
White, D.
;
Branford, S.
;
Hughes, T.
;
Yong, A.
2022
RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid Leukemia.
Shanmuganathan, N.
;
Wadham, C.
;
Thomson, D.
;
Shahrin, N.H.
;
Vignaud, C.
;
Obourn, V.
;
Chaturvedi, S.
;
Yang, F.
;
Feng, J.
;
Saunders, V.
;
Kok, C.H.
;
Yeung, D.
;
King, R.M.
;
Kenyon, R.R.
;
Lin, M.
;
Wang, P.
;
Scott, H.
;
Hughes, T.
;
Schreiber, A.W.
;
Branford, S.
Discover
Author
8
Ross, D.
5
Parker, W.
5
Seymour, J.
4
Braley, J.
4
Grigg, A.
4
Phillis, S.
4
Scott, H.
4
White, D.
3
Arthur, C.
3
Filshie, R.
.
next >
Subject
6
Leukemia, Myelogenous, Chronic, B...
4
Antineoplastic Agents
4
Benzamides
4
Fusion Proteins, bcr-abl
4
Humans
4
Piperazines
4
Pyrimidines
3
Imatinib Mesylate
2
Adult
2
Disease Progression
.
next >
Date issued
1
2020 - 2022
12
2010 - 2019